Biofrontera Inc (BFRI)

$0.66 +0.00 (0.15%)
Market Cap 6.23M
Revenue (ttm) 37.32M
Net Income (ttm) -17.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -47.59%
Debt to Equity Ratio 8.98
Volume 87,100
Avg Vol 168,536
Day's Range N/A - N/A
Shares Out 9.45M
Stochastic %K 65%
Beta 0.29
Analysts Strong Sell
Price Target $5.38

Company Profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatmen...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 245 1325
Address:
120 Presidential Way, Suite 330, Woburn, United States
LION86
LION86 Jun. 16 at 4:24 PM
$BFRI 💪🙏
0 · Reply
ivo98
ivo98 Jun. 13 at 7:57 PM
$BFRI fake hype coming before next offering 🤔🤣
0 · Reply
Chucky91
Chucky91 Jun. 12 at 4:24 PM
$ZVSA we need more volume!!! $AYTU $BFRI
0 · Reply
Ibrahart
Ibrahart Jun. 12 at 2:11 PM
$BFRI after today! She’s going placesss 🥶🥶🥶
0 · Reply
ClenchFists
ClenchFists Jun. 12 at 11:05 AM
$BFRI Loading moar!!!
0 · Reply
ivo98
ivo98 Jun. 11 at 9:45 PM
$BFRI is dead like this forum. They will and come and get it from new bagholders (bulls 🤣) to survive 3 months.
1 · Reply
SimSimBola
SimSimBola Jun. 11 at 8:07 PM
$BFRI they made it so easy for me with today's pr. there is no deal where bfri will get the long end of the stick. and no cash despite the high revenue + coming up on 10M shares OS. it is over! i lost today but overall made money over the last 2 years trading this. removing from watchlist and wishing u guys all the best.
1 · Reply
SimSimBola
SimSimBola Jun. 11 at 8:00 PM
$BFRI sold!
0 · Reply
SimSimBola
SimSimBola Jun. 11 at 7:35 PM
$BFRI and there she goes. it would be the last time she saw 65 cents.
1 · Reply
SimSimBola
SimSimBola Jun. 11 at 7:23 PM
$BFRI cant make 70 cents because everybody want out
0 · Reply
Latest News on BFRI
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

Jun 11, 2025, 3:00 PM EDT - 5 days ago

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

Jun 3, 2025, 2:30 PM EDT - 13 days ago

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript

May 16, 2025, 3:36 PM EDT - 4 weeks ago

Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

May 15, 2025, 5:09 PM EDT - 4 weeks ago

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

May 15, 2025, 12:17 PM EDT - 4 weeks ago

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

May 6, 2025, 12:45 PM EDT - 5 weeks ago

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis

May 1, 2025, 2:38 PM EDT - 6 weeks ago

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis

Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript

Mar 21, 2025, 11:20 AM EDT - 3 months ago

Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

Mar 21, 2025, 8:00 AM EDT - 3 months ago

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk

Mar 18, 2025, 9:30 AM EDT - 3 months ago

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025

Mar 11, 2025, 10:00 AM EDT - 3 months ago

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025

Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Jan 8, 2025, 9:50 AM EST - 5 months ago

Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market

Dec 23, 2024, 9:30 AM EST - 6 months ago

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Dec 3, 2024, 11:00 AM EST - 6 months ago

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note

Nov 22, 2024, 9:10 AM EST - 7 months ago

Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note

Biofrontera Inc. (BFRI) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 3:02 PM EST - 7 months ago

Biofrontera Inc. (BFRI) Q3 2024 Earnings Call Transcript

Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

Nov 13, 2024, 5:15 PM EST - 7 months ago

Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

Nov 1, 2024, 11:55 AM EDT - 8 months ago

Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Oct 31, 2024, 10:32 AM EDT - 8 months ago

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Oct 14, 2024, 10:30 AM EDT - 8 months ago

Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.'s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

Oct 7, 2024, 8:45 AM EDT - 9 months ago

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.'s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 25, 2024, 10:45 AM EDT - 9 months ago

Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference

Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 1:34 PM EDT - 10 months ago

Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 14, 2024, 4:30 PM EDT - 10 months ago

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

Aug 9, 2024, 10:00 AM EDT - 11 months ago

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp

Jun 24, 2024, 8:30 AM EDT - 1 year ago

Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp

Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript

May 16, 2024, 2:44 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript

Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update

May 15, 2024, 4:45 PM EDT - 1 year ago

Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update

Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024

May 6, 2024, 10:30 AM EDT - 1 year ago

Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024

Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants

May 3, 2024, 8:50 AM EDT - 1 year ago

Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants

Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals

Mar 26, 2024, 4:30 PM EDT - 1 year ago

Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals

Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript

Mar 18, 2024, 12:13 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript

CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Mar 15, 2024, 8:25 PM EDT - 1 year ago

CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Mar 15, 2024, 6:10 PM EDT - 1 year ago

Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024

Mar 8, 2024, 9:00 AM EST - 1 year ago

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024

Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer

Mar 5, 2024, 7:30 AM EST - 1 year ago

Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer

Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules

Feb 23, 2024, 8:40 AM EST - 1 year ago

Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules

Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG

Feb 20, 2024, 8:10 AM EST - 1 year ago

Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG

Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules

Feb 20, 2024, 8:05 AM EST - 1 year ago

Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules

Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use

Feb 5, 2024, 5:15 PM EST - 1 year ago

Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use

Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023

Jan 11, 2024, 4:15 PM EST - 1 year ago

Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023

Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript

Nov 10, 2023, 1:54 PM EST - 1 year ago

Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript

Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update

Nov 9, 2023, 5:10 PM EST - 1 year ago

Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update

Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10

Nov 3, 2023, 8:30 AM EDT - 1 year ago

Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10

Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules

Oct 31, 2023, 8:01 AM EDT - 1 year ago

Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules

Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R)

Oct 10, 2023, 9:00 AM EDT - 1 year ago

Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R)

Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

Oct 5, 2023, 9:00 AM EDT - 1 year ago

Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

Biofrontera Inc. Announces Preliminary Third Quarter Revenues

Oct 4, 2023, 8:30 AM EDT - 1 year ago

Biofrontera Inc. Announces Preliminary Third Quarter Revenues

Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts

Aug 29, 2023, 8:00 AM EDT - 1 year ago

Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts

Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R)

Aug 28, 2023, 8:00 AM EDT - 1 year ago

Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R)

LION86
LION86 Jun. 16 at 4:24 PM
$BFRI 💪🙏
0 · Reply
ivo98
ivo98 Jun. 13 at 7:57 PM
$BFRI fake hype coming before next offering 🤔🤣
0 · Reply
Chucky91
Chucky91 Jun. 12 at 4:24 PM
$ZVSA we need more volume!!! $AYTU $BFRI
0 · Reply
Ibrahart
Ibrahart Jun. 12 at 2:11 PM
$BFRI after today! She’s going placesss 🥶🥶🥶
0 · Reply
ClenchFists
ClenchFists Jun. 12 at 11:05 AM
$BFRI Loading moar!!!
0 · Reply
ivo98
ivo98 Jun. 11 at 9:45 PM
$BFRI is dead like this forum. They will and come and get it from new bagholders (bulls 🤣) to survive 3 months.
1 · Reply
SimSimBola
SimSimBola Jun. 11 at 8:07 PM
$BFRI they made it so easy for me with today's pr. there is no deal where bfri will get the long end of the stick. and no cash despite the high revenue + coming up on 10M shares OS. it is over! i lost today but overall made money over the last 2 years trading this. removing from watchlist and wishing u guys all the best.
1 · Reply
SimSimBola
SimSimBola Jun. 11 at 8:00 PM
$BFRI sold!
0 · Reply
SimSimBola
SimSimBola Jun. 11 at 7:35 PM
$BFRI and there she goes. it would be the last time she saw 65 cents.
1 · Reply
SimSimBola
SimSimBola Jun. 11 at 7:23 PM
$BFRI cant make 70 cents because everybody want out
0 · Reply
tushar0077
tushar0077 Jun. 11 at 7:18 PM
$BFRI ready to run big
0 · Reply
SimSimBola
SimSimBola Jun. 11 at 7:15 PM
$BFRI sell it all today.
0 · Reply
tushar0077
tushar0077 Jun. 11 at 7:13 PM
$BFRI wow thiis is big
0 · Reply
GDS100
GDS100 Jun. 11 at 7:11 PM
$BFRI merger ,lets go
0 · Reply
Pehudin
Pehudin Jun. 11 at 7:11 PM
$BFRI wtf is this fake news lmao, its the same company
0 · Reply
SimSimBola
SimSimBola Jun. 11 at 7:05 PM
$BFRI fresh set of bullshit!
0 · Reply
Bulltrader988
Bulltrader988 Jun. 11 at 7:03 PM
$BFRI 👀👀 https://www.stocktitan.net/news/BFRI/biofrontera-inc-is-negotiating-fundamental-changes-to-its-fwhjlysf7lh4.html
0 · Reply
SimSimBola
SimSimBola Jun. 11 at 7:01 PM
$BFRI
0 · Reply
ivo98
ivo98 Jun. 11 at 2:54 PM
$BFRI new license. Beginning of the end?
0 · Reply
ivo98
ivo98 Jun. 11 at 2:38 PM
$BFRI w license and supply agreement with Biofrontera AG coming. Beginning of theend? 🤔
0 · Reply
LION86
LION86 Jun. 5 at 6:53 PM
$BFRI Im here since 12/2021 I lost my family and my money saved for 17 years (average 8 dollars), and when they do another RS, I’m going to lose my life too 🤷‍♂️
0 · Reply
cambam321
cambam321 Jun. 5 at 4:56 AM
$BFRI scamarama ding dong
0 · Reply